- Home»
- The Billing Beat Newsletter»
- AMP Publishes Economic Analysis of Genomic Sequencing Procedures to Support Lab, Payor Discussions
AMP Publishes Economic Analysis of Genomic Sequencing Procedures to Support Lab, Payor Discussions
April 29, 2016The Association of Molecular Pathology has estimated how much it costs laboratories to perform certain genomic sequencing procedures and has modeled the value this testing adds to the overall care of patients. The analysis, published in the Journal of Molecular Diagnostics, provides a snapshot of the resources labs require to perform complex genomic testing and found that these tests could reduce healthcare costs or identify the right treatment strategy for many patients. AMP’s cost analysis comes during a time of rapid growth in the NGS clinical testing market, which payors have countered with significant reimbursement pressure. “A main objective of developing AMP’s microcost and health economic analysis was to assist laboratories in communicating the cost of their genomic sequencing procedure services to Medicare administrative contractors,” lead author Linda Sabatini from NorthShore University HealthSystem told GenomeWeb.